Filing Details
- Accession Number:
- 0001209191-23-022874
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2023-04-04 17:31:30
- Reporting Period:
- 2023-03-31
- Accepted Time:
- 2023-04-04 17:31:30
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1645569 | Dice Therapeutics Inc. | DICE | Pharmaceutical Preparations (2834) | 472286244 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1880979 | R. John Jacobsen | C/O Dice Therapeutics, Inc. 400 East Jamie Court, Suite 300 South San Francisco CA 94080 | Cso | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2023-03-31 | 773 | $30.00 | 182,639 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- The sale reported on this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on October 27, 2022.
Billionaire Hedge Funds
